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Summary
Yeasts as eukaryotic microorganisms with simple, well known
and tractable genetics, have long been powerful model systems for
studying complex biological phenomena such as the cell cycle or
vesicle fusion. Until recently, yeast has been assumed as a cellular
‘clean room’ to study the interactions and the mechanisms of action
of mammalian apoptotic regulators. However, the ﬁnding of an
endogenous programmed cell death (PCD) process in yeast with an
apoptotic phenotype has turned yeast into an ‘unclean’ but even
more powerful model for apoptosis research. Yeast cells appear to
possess an endogenous apoptotic machinery including its own
regulators and pathway(s). Such machinery may not exactly
recapitulate that of mammalian systems but it represents a simple
and valuable model which will assist in the future understanding of
the complex connections between apoptotic and non-apoptotic
mammalian PCD pathways. Following this line of thought and in
order to validate and make the most of this promising cell death
model, researchers must undoubtedly address the following issues:
what are the crucial yeast PCD regulators? How do they play
together? What are the cell death pathways shared by yeast and
mammalian PCD? Solving these questions is currently the most
pressing challenge for yeast cell death researchers.
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INTRODUCTION
Programmed cell death (PCD) refers to an active process
characterized by a course of endogenous molecular events,
representing a form of ‘cell suicide’ (1). PCD is a highly
complex, regulated process requiring the coordinated activa-
tion and execution of multiple sub-programmes that include
both caspase-dependent or – independent mechanisms. Ge-
netically deﬁned PCD programs dictate diﬀerent phenotypes
ranging from apoptotic to necrotic to autophagic, with
intermediate and overlapping forms.
Unlike apoptosis, the non-apoptotic modes of PCD
including programmed necrosis, autophagic cell death and
mitotic catastrophe are still diﬃcult to distinguish unambigu-
ously and remain poorly characterized (2 – 4). For several
years, apoptosis was wrongly understood as synonymous with
PCD and was assumed to be conﬁned to multicellular
organisms, with Caenorhabditis elegans and Drosophila mela-
nogaster being chosen as core models for cell death research.
The completion of the Saccharomyces cerevisiae genome
sequence in 1996 and the initial failures to detect orthologues
of apoptosis-related proteins encoded by the yeast genome,
made yeast a ‘clean room’ system for the study of
heterologous expressed mammalian apoptotic regulators such
as proteins from the Bcl-2 family. Unexpectedly, the
expression of the pro-apoptotic protein Bax in yeast resulted
in cell death (5) with an apoptotic nature (6), which could be
prevented by the co-expression of the antiapoptotic Bcl-2
protein suggesting some speciﬁcity of the killing eﬀect (5). It
is seven years since the yeast S. cerevisiae appeared as the
simplest eukaryotic organism displaying PCD with an
apoptotic phenotype (7). Since then the number of reports
of this phenomenon increases almost daily, leading to the
emergence of a new, fruitful and promising research ﬁeld that
proﬁts from the recognized advantages of yeasts for the study
of biological processes.
In our opinion, it is now time to look carefully into the
phenomenon and to ﬁnd answers to some urgent questions:
what are the yeast apoptotic regulators? How do they play
together? What are the cell death pathways shared by yeasts
and mammals? Finally, are we in danger of over interpreting
the data concerning apoptosis and disregarding the possible
occurrence of non-apoptotic PCD processes as has happened
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in the last decades with the study of cell death in mammalian
systems? These are the current major challenges for research-
ers in the yeast apoptosis ﬁeld that will be discussed in the
following sections.
YEAST APOPTOSIS TRIGGERS
The ﬁrst observations of yeast PCD were made on a S.
cerevisiae strain harbouring a mutation in the CDC48 gene
which encodes a protein required for vesicle traﬃcking (7).
Surprisingly, dying cells of this mutant displayed an apoptotic
phenotype characterized by several hallmark mammalian
apoptotic markers such as phosphatidylserine exposure,
condensation and margination of chromatin and DNA
fragmentation. Soon after the discovery that the CDC48
mutant could undergo a form of PCD, researchers showed
that exogenous toxic agents such as hydrogen peroxide (8) or
acetic acid (9) trigger PCD with an apoptotic phenotype in S.
cerevisiae. From hereon, several reports have implicated the
impairment of diﬀerent cellular functions caused by diﬀerent
exogenous stress stimuli or deletion of certain genes in the
induction of an apoptotic phenotype in S. cerevisiae (see
reviews 10, 11). Conditions triggering a yeast apoptotic
phenotype include sugar (12) and salt (13) stresses; starvation
for carbon source on expired medium (14) or of essential
amino acids like lysine and histidine in auxotrophic cells (15);
impairment of exocytosis by deletion of the SRO7/SOP1-
encoded tumor suppressor homologue (16), DNA damage (see
review 11) and truncation or deletion of genes encoding
proteins involved in mRNA stability (17) and cell-cell
communication (18).
Yeast apoptotic cell death processes have also been linked
to other physiological traits such as aging. Curiously,
mutations leading to an increase in actin dynamics promote
yeast longevity, whereas decreased actin dynamics causes an
enhanced metacaspase activity and mitochondrial membrane
depolarization leading to an augment in reactive oxygen
species (ROS) and cell death (19). The described role of actin
cytoskeleton dynamics in the regulation of yeast apoptosis
(19) indicates that this pathway may likely be part of the
natural aging process in yeasts and potentially in mammalian
cells as well, reinforcing the use of yeasts as model organisms
for research on cell aging and death. In fact, yeast cells dying
after chronological aging display stereotypical apoptotic
markers indicating that long-term cultivation can induce
altruistic mortality of an apoptotic nature. The elimination of
old cells, that are less robust and may become deleterious to
the well being of the population, confers a selective and
adaptative advantage for the healthier members of the
community (14). Recently, yeasts were shown to undergo
‘programmed aging’ involving a cell death process mediated
partially by superoxide (20). These authors propose that
early death and high mutation frequency have evolved to
promote early adaptation. Mutations increasing longevity
and antioxidant protection or the overexpression of super-
oxide dismutases and catalase or deletion of the yeast
metacaspase were proven to aﬀect adaptative regrowth,
raising the possibility that natural selection has prevented
alleles that confer longevity extension from becoming ﬁxed
(20).
The number of reports implicating and relating yeast
apoptotic PCD with diverse cellular functions increases daily
but the gaps in our knowledge regarding yeast cell death
pathways and regulators presses us even further towards the
necessity for a greater understanding of yeast PCD processes.
ROS, METACASPASE, CYTOCHROME C, APOPTOSIS
INDUCING FACTOR AND HTRA2/OMI: HOW DO THEY
PLAY TOGETHER?
Given the evidence in favour of yeast PCD it is pertinent to
ask how is the yeast cell death program regulated when most
of the crucial regulator genes known in mammalian systems
are missing? From the beginning, yeast PCD with an apoptotic
phenotype was associated with ROS production leading to the
assumption that these radicals were the only regulators in
yeast apoptotic cell death. However, the precise role of ROS in
PCD is still matter of controversy even in mammalian systems.
Indeed, the intracellular redox state has been shown to
modulate the permeability transition pore opening (21), cell
cycle checkpoints (22), p53 transactivation (23) and caspase-3
activity (24). Alternatively, ROS might only be secondary
apoptotic messengers resulting from the upstream activation
of the PCD machinery. In S. cerevisiae, ROS accumulation is
apparent in almost every apoptotic scenario and probably
plays a causal role. This may point to an ancestral mechanism
of apoptotic regulation, although one should not discard the
possibility that ROS have a dual character in yeast PCD,
acting as secondary apoptotic messengers and/or regulators of
the process.
The description of a yeast metacaspase (YCA1), a caspase-
related protease with caspase activity (25), has altered how
science is looking into the phenomenon of apoptosis in yeasts
because for the ﬁrst time a speciﬁc molecule can be implicated
as an executor of a wide range of apoptotic stimuli. The
discovery of a yeast molecule homologous to human caspases,
that when disrupted rescues yeasts from a variety of diﬀerent
lethal stimuli, reinforces the concept of an ancestral PCD
machinery in yeast cells. In the mammalian apoptotic process
the activation of the ‘executioner’ caspases and subsequent
cleavage of their substrates within the cell can be linked
directly to the characteristic morphological and biochemical
features of the apoptotic phenotype. Although the phenoty-
pical alterations observed in yeast cells dying by PCD resemble
the apoptotic phenotype observed in mammalian cells, there
are no known yeast metacaspase substrates; therefore the role
of the caspase-like protein Yca1p in yeasts is still poorly
understood.
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Cytochrome c (cyt c) is another molecule implicated in
yeast apoptosis. Resembling mammalian systems, yeast cyt c is
translocated from mitochondria to the cytosol under apoptotic
conditions such as Bax expression (26), deletion of the histone
chaperone ASF1/CIA1 (27), acetic acid treatment (28) and
PCD induction by mating pheromone (18). Moreover, cells
without mature cyt c were shown to be more resistant to death
induced by acetic acid (28). However, the interaction of cyt c
with other cytoplasmic proteins has so far not been revealed
and the elucidation of the speciﬁcity of its release from
mitochondria is yet to be demonstrated.
Two basic key players of mammalian apoptosis, HtrA2/
Omi and Apoptotic Inducing Factor (AIF), were shown to be
present in the yeast genome (29, 30). Fahrenkrog and
coworkers (29) identiﬁed and characterized Nma111p, an
HtrA-like protein of S. cerevisiae, that under certain stress
conditions, aggregates inside the nucleus mediating yeast
apoptotic PCD. In addition, we have proven that Aif1p a yeast
homologue of mammalian Aifp is also a cell death mediator
that is translocated from mitochondria to the nucleus in
response to apoptotic stimuli (30). Recently, yeast homologues
of mitochondrial ﬁssion factors such as FIS1 and DNM1 were
reported to also regulate yeast PCD, suggesting one more
cellular process involved in yeast and mammalian PCD
processes (31).
Although these advances have highlighted the existence of
an ancestral apoptotic machinery in S. cerevisiae sharing
amazing homologies with that of mammalian systems, all of
them constitute pieces of a puzzle that is far from being solved.
Besides the observation that the eﬀect of Aif1p overexpression
is attenuated by disruption of YCA1 (30), no other relation-
ships have been established between the currently identiﬁed
yeast apoptotic players. The clariﬁcation of the hierarchy of
these yeast cell death players as well as their interactions
during apoptosis will allow the drawing of the yeast PCD
pathway(s), further contributing to the elucidation of the roots
of apoptotic PCD in higher eukaryotes.
YEAST APOPTOTIC PATHWAY(S)?
As previously discussed, it is still not possible to outline the
putative death pathway(s) playing in yeast apoptotic PCD due
to the lack of knowledge concerning the interactions between
the few identiﬁed regulators. Once again, it is necessary to
stress that at this point yeast cell death researchers must focus
on this issue in order to further validate and take advantage of
this promising cell death model. Results described in literature
suggest that similar to mammalian cells, yeast cells would also
possess diﬀerent apoptotic pathways. Some of those results
clearly show a crucial involvement of mitochondria in a
number of apoptotic PCD pathways triggered by diﬀerent
stimuli or deletion of some genes. Manon and coworkers (26)
pointed out that Bax-induced growth arrest of yeast cells is
related to defects in the respiratory chain such as a decrease in
the amount of cytochrome c oxidase (COX) complex and the
release of cyt c to the cytosol.
On the other hand, the S. cerevisiae strain lacking the
histone chaperone ASF1/CIA1 also displayed mitochondrial
dysfunctions associated to typical apoptotic markers includ-
ing a reduction of the mitochondrial membrane-potential,
dysfunction of the mitochondrial proton pump, and release
of cyt c to cytoplasm (27). Our previous results showed that
acetic acid-induced apoptosis in S. cerevisiae is also mediated
by a mitochondria-dependent apoptotic pathway (28): release
of cyt c and ROS production were associated with a
reduction in oxygen consumption and a decline of COX
activity coupled with a speciﬁc decrease in the amounts of
COX II subunit. An apoptotic phenotype related to
mitochondria was also observed in yeast cells subjected to
DNA damage due to a mutation in the CDC13 gene which
encodes a yeast telomere binding protein with an essential
role in protecting yeast telomeres (32). In fact, mitochondrial
proteins have been identiﬁed as multicopy suppressors of cell
death in the CDC13 mutant strain. Transformation with a
human HeLa cDNA library produced one clone that was
identiﬁed as the mitochondrial protein MTOC3 (subunit 3 of
human COX) while transformation with a yeast genomic
library produced two clones identiﬁed as fragments of
YDR333C and antisense of CYC8. YDR333C was found
to interact with the mitochondrial ribosomal protein Mrp51p
(involved in the regulation of the expression of subunits 2
and 3 of yeast COX) and CYC8 encodes a protein that
regulates expression of COX3 and COX6 of COX. Interest-
ingly, these suppressors are directly or indirectly related to
mitochondrial COX whose inhibition is known to trigger
apoptosis in mammalian cells (33, 34). Somehow, data
available concerning yeast cell death induced by Bax
expression, acetic acid treatment or deletion of either
ASF1/CIA1 or CDC13 genes, clearly point out that COX
complex is playing a role in yeast apoptosis resembling
mammalian systems. Mitochondria involvement in yeast
apoptosis was also supported by recent results indicating
that mitochondrial fragmentation is also regulating yeast
PCD (31). Moreover, mitochondria have been implicated at a
general level in yeast PCD by the results obtained with the
rho0 mutant strain (lacking mitochondrial DNA), revealing
that the apoptotic signals induced by Bax expression, acetic
acid treatment or deletion of CDC13 were suppressed in a
rho0 mutant (26, 28, 32). Curiously, the rho0 strain is able to
undergo hydrogen peroxide- (our unpublished results) or
essential amino acid starvation-induced apoptosis (15)
suggesting a diﬀerent role for mitochondria in these
apoptotic processes. Supporting these results, yeast metacas-
pase, the described executor of PCD induced by a wide range
of apoptotic stimuli, has a signiﬁcantly lower activity in cells
dying by acetic acid treatment when compared with the
activity seen in cells dying by hydrogen peroxide exposure
(25). These results suggest that acetic acid-induced PCD
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would be strictly dependent on mitochondria activating an
intrinsic-like pathway, while the one triggered by hydrogen
peroxide would be mitochondria-independent using mito-
chondria only as an ampliﬁcation signal in an extrinsic-like
pathway. Moreover, even DYCA1 cells show rapid death in
presence of high concentrations of the described apoptotic
inducing agents, indicating the presence of alternative
mechanisms of cell death. Altogether, these data can be used
to suggest in all probability the existence of more than one
cell death pathway in yeasts.
Apoptotic proteins such as BI-1 or IAP have counterparts
in yeast cells (35, 36), but they have not yet been implicated
in yeast PCD. The role of Bir1p (a yeast IAP homologue) on
yeast PCD and its putative role on the regulation of
metacaspase has not been studied so far. However, as
suggested by Fahrenkrog and coworkers (29), Yca1p,
Nma111p and Bir1p could be engaged in the regulation of
yeast PCD in a similar way to their mammalian homologues.
Furthermore, because of Nma111p and Bir1p nuclear
localization, the nucleus appears to play a signiﬁcant role
in yeast apoptosis (29). Future studies regarding these
putative orthologue proteins might contribute to a better
understanding of yeast PCD as the genetic tractability of
these microorganisms may lead to the implication of other
proteins in yeast associated PCD pathway(s). Nevertheless,
the evolutionary roots of PCD processes still remain a
mystery and the elucidation of yeast PCD pathway(s)
appears as one of the greatest challenges for yeast cell death
researchers.
YEAST AS AN ‘UNCLEAN’ MODEL FOR APOPTOSIS
RESEARCH
As stated earlier, yeast has proven to be a powerful model
system for studying complex biological phenomena and was
considered to be a ‘clean room’ system for examining the
eﬀect of heterologous expression of pro- and anti-apoptotic
mammalian proteins as well as the identiﬁcation of novel
apoptotic activators or inhibitors (37 – 39). In fact, genetic
screens allowed the identiﬁcation of mitochondrial subunits
(e.g., from mitochondrial F0F1-ATPase proton pump) as
critical for Bax-mediated killing in S. cerevisiae (37) and
novel Bax inhibitors such as Bax inhibitor-1 (BI-1) (38) or
Ku70 (39). The lethal eﬀect of the expression of several
mammalian pro-apoptotic regulators such as Bax (5) or
caspases (40) although fruitful for the study of those
regulators, was always intriguing for scientists. For several
years the rescue of cell lethality, caused by expression of Bax
or Bak by co-expression of anti-apoptotic proteins such as
Bcl-2 or Bcl-xl, was not considered evidence in favour of the
existence of an endogenous PCD process. Several authors
argued that in most cases this suppression would be due to
direct binding of the mammalian anti-apoptotic proteins to
their mammalian apoptotic-promoting counterparts. None-
theless, the occurrence of a yeast endogenous PCD process is
no longer a subject for speculation as an ancestral PCD
machinery is undoubtedly present in this unicellular eukar-
yote. Ascertaining whether or not the rescue by anti-
apoptotic proteins of lethality induced by expression of Bax
or Bak is due to direct binding of the mammalian anti-
apoptotic proteins to their mammalian apoptosis-promoting
counterparts or to the inactivation of the yeast endogenous
PCD program is still a matter of debate. It is clearly
important to recognize that yeasts must be viewed as an
‘unclean system’ to study pro- and anti-apoptotic mamma-
lian proteins. The employment of yeasts as models for
apoptosis research to investigate the functions and interac-
tions of heterologously expressed mammal proteins should
not ignore the existence of an endogenous yeast PCD
pathway. In fact, one must consider the possibility that the
heterologously expressed apoptotic regulator proteins could
somehow interact with the native machinery that promotes
or inhibits the endogenous yeast PCD. Therefore, one should
take into consideration that even though yeasts are an
‘unclean system’ they are still a promising model for
apoptosis research, provided that all the results are analysed
and interpreted in light of the existence of an endogenous
yeast PCD pathway(s).
YEAST AND NON-APOPTOTIC PCD
The mechanisms that regulate non-apoptotic cell death
remain even more dubious than those that regulate apoptosis.
Yeast contributions have considerably promoted our under-
standing of several aspects of non-apoptotic PCD and are
expected to increase in the near future.
Necrotic PCD, an active controlled cell death process
with a phenotype reminiscent of passive accidental necrosis,
has been found to be implicated in several instances of
neurodegeneration, inﬂammatory diseases, infection and
ischemia (2 – 4). In this form of PCD, apoptotic markers
are lacking; instead, the cell membrane is damaged early,
organelles are disorganized and the cell swells and even-
tually lyses. Instances of programmed necrosis occur after
triggering of TNF or Fas death receptors when apoptosis is
chemically or genetically blocked (reviewed in 41). In these
situations PARP (poly ADP-ribose polymerase) is not
cleaved by caspases and leads to energy depletion resulting
in death. Programmed necrosis can be triggered in more
‘natural’ situations, namely in viral infections where
participation of RIP or the serine protease activity of
HtrA2/Omi have been implicated (41). In many instances of
programmed necrosis, pieces of the apoptotic death machin-
ery are shared by the necrotic death program. However, the
ﬁnal stages of the necrotic process require the utilization of
speciﬁc genes including those encoding for enzymes used in
the terminal dismantlement of the dying cell, like calpains
and cathepsins (42).
132 LUDOVICO ET AL.
Even though mechanisms of programmed necrosis are
conserved from worms and ﬂies to humans (42), programmed
necrosis has not been speciﬁcally studied in yeasts. However, it
is important to bear in mind that contrary to apoptosis in
multicellular organisms, where apoptotically dying cells are
removed and eliminated by scavenger cells before being lysed
by a terminal necrotic process (post-apoptotic secondary
necrosis), apoptosis in yeast inevitably ends with the lytic
disintegration of the doomed cells. This has been a source of
confusion in the characterization of yeast apoptotic processes,
because necrosis indicators (like cell membrane damage) can
occur in an otherwise typical apoptotic process. The same
problem arises in studies concerning apoptosis using in vitro
cultured mammalian cell lines. Primary necrosis, but not
programmed necrotic cell death, was observed when S.
cerevisiae (9), Zygosaccharomyces bailii (43) or Candida
albicans (44) were exposed to high concentrations of acetic acid.
Autophagic cell death (ACD) refers to a separate form of
PCD where autophagy is excessive and lysosomal activity
exaggerated, leading to active destruction of the cytoplasm
before nuclear changes become apparent (45). ACD has been
observed in several physiological situations in embryogenesis
and in adulthood and has been associated with the pathogen-
esis of some neurodegenerative disorders and cancer. Studies
on yeast autophagy have been instrumental in the advance of
the understanding of autophagy and ACD, with most
autophagy-related genes identiﬁed and characterized by
genetic analysis in yeasts (46). Genome sequence analysis
have revealed that similar genes are implicated in autophagy in
worms, ﬂies and humans, and links between yeast autophagy
genes and human cell death have also been made (47). Yeast
cells undergo autophagic death when arrested at any stage of
the cell cycle (48, 49) or following activation of protein
phosphatase 2A (50). The borderline between ACD and
apoptosis can be unclear and links between both cell death
pathways have been disclosed (51), indicating the possibility of
some overlapping or interdependence between them (3).
Mitotic catastrophe represents a less debated form of
caspase-independent PCD caused in mammalian cells and
yeasts by aberrant mitosis. It was initially described in
Schizosaccharomyces pombe (52), although its PCD character
was not recognized at that time. The regulatory mechanisms of
this peculiar form of cell demise remain to be elucidated (4).
So far, few biological models have been used to investigate
PCD mechanisms. A large extent of the knowledge in the PCD
ﬁeld, which as reviewed here is still very scarce, resulted from
the use of two invertebrate (C. elegans and D. melanogaster)
and two vertebrate (human and mouse) animal models.
Despite the contribution of these models to our current
understanding of cell death, further progress in the resolution
of a number of questions resulted from the parallel use of
classical and alternative biological models (53). The lessons
learned from yeast PCD, besides yielding new insights into the
evolution of the apoptotic pathways in eukaryotic cells, will
produce knowledge relevant to human health. One should
keep in mind that the easy genetic manipulation of yeast cells
may not always be beneﬁcial and could reveal a ‘dark side’.
The genetic plasticity of yeast cells allows them to readapt to
new conditions when genes are deleted giving rise to
pleiotropic resistances. Consequently, ‘innocent bystander’
genes could be misinterpreted as relevant genes, leading to the
necessity of a multifaceted approach to properly implicate
their product on yeast PCD. Although yeasts have turned out
to be important models in cell death research, they are unlikely
to reveal all the aspects of complex cell death mechanisms in
multicellular organisms.
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